Sigma1 Receptor Inhibits TRPC1-Mediated Ca2+ Entry That Promotes Dopaminergic Cell Death

Yuyang Sun1, Pramod Sukumaran1, Brij B Singh2

  • 1Department of Periodontics, University of Texas Health Science Center San Antonio, San Antonio, TX, 78229, USA.

Insights

The sigma 1 receptor blocks calcium (Ca2+) entry through TRPC1 channels, causing dopaminergic cell death. Inhibiting the sigma 1 receptor protects these neurons, offering a potential treatment for Parkinson's disease.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Neuronal function relies on calcium (Ca2+) homeostasis.
  • TRPC1 channels are crucial for store-mediated Ca2+ entry in dopaminergic cells, and their dysfunction leads to neurodegeneration.
  • The precise regulation of TRPC1 channels remains incompletely understood.

Purpose of the Study:

  • To investigate the role of the sigma 1 receptor in regulating TRPC1-mediated Ca2+ entry.
  • To determine if the sigma 1 receptor contributes to neurotoxin-induced dopaminergic cell loss.
  • To explore the therapeutic potential of targeting the sigma 1 receptor for neuroprotection.

Main Methods:

  • Utilized MTT assays and caspase activity measurements to assess cell viability and apoptosis.
  • Performed calcium imaging to measure store-dependent Ca2+ influx.
  • Investigated protein interactions using co-immunoprecipitation and assessed receptor-STIM1 association upon store depletion.
  • Examined the effects of sigma 1 receptor modulation (downregulation, activation, antagonism) on TRPC1 function and neurodegeneration.

Main Results:

  • Sigma 1 receptor activation inhibited TRPC1-mediated Ca2+ entry and promoted neurotoxin-induced dopaminergic cell death.
  • Downregulation or antagonism of the sigma 1 receptor restored Ca2+ influx and conferred significant neuroprotection.
  • Silencing TRPC1 or STIM1 blocked store-mediated Ca2+ entry, and this effect was exacerbated by sigma 1 receptor downregulation.
  • TRPC1 silencing negated the neuroprotective effects of sigma 1 receptor downregulation.

Conclusions:

  • The sigma 1 receptor actively inhibits TRPC1-mediated Ca2+ entry, contributing to dopaminergic neurodegeneration.
  • Targeting the sigma 1 receptor represents a promising strategy for preventing neuronal cell death in conditions like Parkinson's disease.
  • Modulating sigma 1 receptor activity can restore essential Ca2+ homeostasis and protect vulnerable neurons.

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.6K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.7K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.4K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K